{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:48:45Z","timestamp":1794383325213,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P30-EY005722-35"],"award-info":[{"award-number":["5P30-EY005722-35"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY024485"],"award-info":[{"award-number":["R01EY024485"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY030283"],"award-info":[{"award-number":["R01EY030283"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ajo.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T10:59:51Z","timestamp":1663930791000},"page":"42-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage"],"prefix":"10.1016","volume":"247","author":[{"given":"Victor L.","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Soifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9674","key":"10.1016\/j.ajo.2022.09.009_bib0001","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri3226","article-title":"Emerging concepts in haematopoietic cell transplantation","volume":"12","author":"Li","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0003","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.ajo.2022.09.009_bib0004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1-3","key":"10.1016\/j.ajo.2022.09.009_bib0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12026-013-8450-7","article-title":"The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success","volume":"57","author":"Newman","year":"2013","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease","volume":"90","author":"Franklin","year":"1983","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0007","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1983.01040010580010","article-title":"The eye in bone marrow transplantation: I. Clinical study","volume":"101","author":"Hirst","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.09.009_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s40135-020-00227-z","article-title":"Ocular graft-versus-host disease topic review","volume":"8","author":"Mousa","year":"2020","journal-title":"Curr Ophthalmol Rep"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/ICU.0b013e32833eab64","article-title":"Current insights into ocular graft-versus-host disease","volume":"21","author":"Riemens","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2022.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2022.09.009_bib0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jtos.2018.04.001","article-title":"Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center","volume":"16","author":"Berchicci","year":"2018","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ajo.2022.09.009_bib0012","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","article-title":"Ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"29","author":"Westeneng","year":"2010","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ajo.2022.09.009_bib0013","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archopht.1989.01070020413046","article-title":"The eye in bone marrow transplantation: III. Conjunctival graft-vs-host disease","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"suppl","key":"10.1016\/j.ajo.2022.09.009_bib0014","first-page":"S177","article-title":"Ocular graft vs. host disease","volume":"3","author":"Kim","year":"2005","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0015","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2022.09.009_bib0016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-1-4615-5359-5_45","article-title":"Meibomian secretions in chronic blepharitis","volume":"438","author":"McCulley","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00003226-199107000-00001","article-title":"Meibomian gland dysfunction in chronic blepharitis","volume":"10","author":"Mathers","year":"1991","journal-title":"Cornea"},{"issue":"Pt 4","key":"10.1016\/j.ajo.2022.09.009_bib0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/eye.1991.65","article-title":"Meibomian gland disease. Classification and grading of lid changes","volume":"5","author":"Bron","year":"1991","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0019","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2022.09.009_bib0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jtos.2021.03.009","article-title":"Meibomian gland dysfunction is suppressed via selective inhibition of immune responses by topical LFA-1\/ICAM antagonism with lifitegrast in the allergic eye disease (AED) model","volume":"21","author":"Singh","year":"2021","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajo.2022.09.009_bib0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","article-title":"Management of meibomian gland dysfunction: a review","volume":"65","author":"Sabeti","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2022.09.009_bib0022","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2022.09.009_bib0023","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ophtha.2012.03.004","article-title":"Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease","volume":"119","author":"Denoyer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2022.09.009_bib0024","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajo.2020.05.035","article-title":"Prevalence of persistent corneal epithelial defects in chronic ocular graft-versus-host disease","volume":"218","author":"Sinha","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2022.09.009_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2020.03.044","article-title":"Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey","volume":"216","author":"Dana","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0026","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A review of ocular graft-versus-host disease: pathophysiology, clinical presentation and management","volume":"29","author":"Carreno-Galeano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2022.09.009_bib0027","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2147\/OPTH.S139894","article-title":"Intense pulsed light for evaporative dry eye disease","volume":"11","author":"Dell","year":"2017","journal-title":"OPTH"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0028","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1084\/jem.183.6.2645","article-title":"The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice","volume":"183","author":"Baker","year":"1996","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0029","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1073\/pnas.94.4.1366","article-title":"Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function","volume":"94","author":"Baker","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0030","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1167\/iovs.14-15630","article-title":"Recruitment of donor T cells to the eyes during ocular GVHD in recipients of MHC-matched allogeneic hematopoietic stem cell transplants","volume":"56","author":"Herretes","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2022.09.009_bib0031","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbmt.2016.07.012","article-title":"Novel scoring criteria for the evaluation of ocular graft-versus-host disease in a preclinical allogeneic hematopoietic stem cell transplantation animal model","volume":"22","author":"Perez","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.ajo.2022.09.009_bib0032","doi-asserted-by":"crossref","first-page":"87012","DOI":"10.1172\/jci.insight.87012","article-title":"Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy","volume":"1","author":"Ahadome","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0033","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ijms23010184","article-title":"Analyses and correlation of pathologic and ocular cutaneous changes in murine graft versus host disease","volume":"23","author":"Levy","year":"2021","journal-title":"IJMS"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0034","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41385-018-0089-1","article-title":"Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model","volume":"12","author":"Saban","year":"2019","journal-title":"Mucosal Immunol"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1167\/iovs.04-0741","article-title":"Visualization and characterization of inflammatory cell recruitment and migration through the corneal stroma in endotoxin-induced keratitis","volume":"47","author":"Carlson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2022.09.009_bib0036","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273940701486803","article-title":"Ocular surface disease index for the diagnosis of dry eye syndrome","volume":"15","author":"Ozcura","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0037","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clae.2012.10.074","article-title":"Comparison of subjective grading and objective assessment in meibography","volume":"36","author":"Pult","year":"2013","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ajo.2022.09.009_bib0038","unstructured":"Pult H. Improved meiboscale for meibography. Published online 2016. doi:10.13140\/RG.2.2.16178.40649"},{"issue":"4","key":"10.1016\/j.ajo.2022.09.009_bib0039","first-page":"221","article-title":"Report of the National Eye Institute\/industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0040","article-title":"Mucosal-associated invariant T cell responses differ by sex in COVID-19","volume":"2","author":"Yu","year":"2021","journal-title":"Med (N Y)"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2012.09.018","article-title":"MMP9 regulates the cellular response to inflammation after skeletal injury","volume":"52","author":"Wang","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.ajo.2022.09.009_bib0042","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.pmbts.2017.02.001","article-title":"Matrix metalloproteinases in myocardial infarction and heart failure","volume":"147","author":"DeLeon-Pennell","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ajo.2022.09.009_bib0043","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jtos.2020.10.003","article-title":"Matrix metalloproteinase 9 positivity predicts long term decreased tear production","volume":"19","author":"Soifer","year":"2021","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0044","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.8.6.6","article-title":"The role of meibography in the diagnosis of meibomian gland dysfunction in ocular surface diseases","volume":"8","author":"Robin","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2022.09.009_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108502","article-title":"The cornea IV immunology, infection, neovascularization, and surgery chapter 1: corneal immunology","volume":"205","author":"Mousa","year":"2021","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0046","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2011.11.030","article-title":"Impact of ocular surface symptoms on quality of life in a United States veterans affairs population","volume":"153","author":"Pouyeh","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2022.09.009_bib0048","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.ophtha.2015.04.011","article-title":"Vision-related quality of life in patients with ocular graft-versus-host disease","volume":"122","author":"Saboo","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2022.09.009_bib0049","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.bbmt.2019.08.001","article-title":"Modeling chronic graft-versus-host disease in MHC-matched mouse strains: genetics, graft composition, and tissue targets","volume":"25","author":"M\u00fcller","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ajo.2022.09.009_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2016.12.026","article-title":"Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients","volume":"176","author":"Arafat","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.09.009_bib0051","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2022.09.009_bib0052","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jtos.2013.12.001","article-title":"Evaluation of an automated thermodynamic treatment (LipiFlow\u00ae) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial","volume":"12","author":"Finis","year":"2014","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.ajo.2022.09.009_bib0053","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","article-title":"A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease","volume":"123","author":"Abud","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2022.09.009_bib0054","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/ICO.0b013e3181e456f0","article-title":"Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%","volume":"29","author":"Malta","year":"2010","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajo.2022.09.009_bib0055","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/bmt.2012.56","article-title":"Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria","volume":"47","author":"Jacobs","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ajo.2022.09.009_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636789","article-title":"Use of post-transplant cyclophosphamide treatment to build a tolerance platform to prevent liquid and solid organ allograft rejection","volume":"12","author":"Lightbourn","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ajo.2022.09.009_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102933","article-title":"Autoimmunity in dry eye disease\u2014an updated review of evidence on effector and memory Th17 cells in disease pathogenicity","volume":"20","author":"Chen","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajo.2022.09.009_bib0058","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jtos.2020.05.009","article-title":"The role of Th17 immunity in chronic ocular surface disorders","volume":"19","author":"Fan","year":"2021","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2022.09.009_bib0059","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The immunological basis of dry eye disease and current topical treatment options","volume":"36","author":"Periman","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"451","key":"10.1016\/j.ajo.2022.09.009_bib0060","doi-asserted-by":"crossref","first-page":"eaas9164","DOI":"10.1126\/scitranslmed.aas9164","article-title":"Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice","volume":"10","author":"Reyes","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ajo.2022.09.009_bib0061","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2022.09.009_bib0062","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/ICO.0b013e3181ea9a6b","article-title":"Immune processes and pathogenic fibrosis in ocular chronic graft-versus-host disease and clinical manifestations after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Ogawa","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2022.09.009_bib0063","first-page":"2533","article-title":"Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy","volume":"17","author":"Ban","year":"2011","journal-title":"Mol Vis"},{"issue":"12","key":"10.1016\/j.ajo.2022.09.009_bib0064","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-12-290403","article-title":"Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new","volume":"117","author":"Coghill","year":"2011","journal-title":"Blood"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422003658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422003658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:16:32Z","timestamp":1777407392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422003658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"alternative-id":["S0002939422003658"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.09.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meibomian Gland Dysfunction: A Route of Ocular Graft-Versus-Host Disease Progression That Drives a Vicious Cycle of Ocular Surface Inflammatory Damage","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}